Advertisement

Advertisement

JP:4578 Stock Latest News

Otsuka Advances ¥50 Billion Share Buyback Program on Tokyo Market

Company AnnouncementsOtsuka Advances ¥50 Billion Share Buyback Program on Tokyo Market

Otsuka to Buy Transcend Therapeutics to Deepen Push Into Next-Generation Psychiatric Drugs

PremiumCompany Announcements

Otsuka to Buy Transcend Therapeutics to Deepen Push Into Next-Generation Psychiatric Drugs

17d ago

Otsuka Holdings Grants Restricted Stock to Directors Tied to Medium-Term Performance Targets

PremiumCompany Announcements

Otsuka Holdings Grants Restricted Stock to Directors Tied to Medium-Term Performance Targets

17d ago

Otsuka Holdings Begins Execution of ¥50 Billion Share Buyback Program

PremiumCompany Announcements

Otsuka Holdings Begins Execution of ¥50 Billion Share Buyback Program

1M ago

Otsuka Holdings to Repurchase and Cancel Up to ¥50 Billion in Shares

PremiumCompany Announcements

Otsuka Holdings to Repurchase and Cancel Up to ¥50 Billion in Shares

2M ago

Otsuka Weighs Investment Unit Cut to Attract Individual Investors

PremiumCompany AnnouncementsOtsuka Weighs Investment Unit Cut to Attract Individual Investors

2M ago

Otsuka Holdings’ Nonconsolidated Profit Falls on Lower Subsidiary Dividends

Company Announcements

Otsuka Holdings’ Nonconsolidated Profit Falls on Lower Subsidiary Dividends

2M ago

Otsuka Holdings Posts Profit Surge in 2025 but Guides to Lower Earnings in 2026

Company Announcements

Otsuka Holdings Posts Profit Surge in 2025 but Guides to Lower Earnings in 2026

2M ago

OTSKF Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

OTSKF Upcoming Earnings Report: What to Expect?

2M ago

Otsuka upgraded to Overweight from Equal Weight at Morgan Stanley

PremiumThe Fly

Otsuka upgraded to Overweight from Equal Weight at Morgan Stanley

3M ago

Otsuka’s VOYXACT Gains FDA Approval for IgAN Treatment

PremiumCompany Announcements

Otsuka’s VOYXACT Gains FDA Approval for IgAN Treatment

5M ago

Cullinan Therapeutics and partners initiate NDA application for zipalertinib

PremiumThe Fly

Cullinan Therapeutics and partners initiate NDA application for zipalertinib

5M ago

Otsuka’s Sibeprenlimab Shows Promising Results in IgAN Treatment

PremiumCompany AnnouncementsOtsuka’s Sibeprenlimab Shows Promising Results in IgAN Treatment

5M ago

Otsuka Holdings Reports Strong Nine-Month Earnings Growth

Company Announcements

Otsuka Holdings Reports Strong Nine-Month Earnings Growth

5M ago

Otsuka Holdings Reports Strong Financial Growth and Expands Consolidation

Company Announcements

Otsuka Holdings Reports Strong Financial Growth and Expands Consolidation

5M ago

OTSKF Upcoming Earnings Report: What to Expect?

PremiumPre-Earnings

OTSKF Upcoming Earnings Report: What to Expect?

6M ago

Otsuka Holdings Completes Strategic Share Transfer

PremiumCompany Announcements

Otsuka Holdings Completes Strategic Share Transfer

7M ago

FDA Issues Complete Response Letter to Otsuka and Lundbeck for PTSD Treatment

PremiumCompany Announcements

FDA Issues Complete Response Letter to Otsuka and Lundbeck for PTSD Treatment

7M ago

Otsuka Holdings Amends Share Transfer Agreement for Otsuka Medical Devices

PremiumCompany Announcements

Otsuka Holdings Amends Share Transfer Agreement for Otsuka Medical Devices

8M ago

Otsuka Holdings Reports Strong Growth in H1 2025

PremiumCompany AnnouncementsOtsuka Holdings Reports Strong Growth in H1 2025

9M ago

Otsuka Holdings Reports Strong H1 2025 Financial Results and Increases Dividend Forecast

Company Announcements

Otsuka Holdings Reports Strong H1 2025 Financial Results and Increases Dividend Forecast

9M ago

Otsuka Holdings Increases Interim and Annual Dividend Forecast

Company Announcements

Otsuka Holdings Increases Interim and Annual Dividend Forecast

9M ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >